{"ticker": {"uuid": "74ff1f08-7a55-4ab2-960c-a9ea0b2fd0a8", "symbol": "TNG", "name": "Transgene SA", "exchange": "PAR", "country": "FR", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Transgene SA (TRGNF) Discusses Progress in Individualized Neoantigen Therapeutic Vaccines and Expansion into Early-Stage NSCLC - Slideshow (OTCMKTS:TRGNF) 2026-07-01", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxPUXVHYkNmT3JRdGZaa2Q0UC0ybFpOdHpOcmN2TWhpWEZnWjY4WUl1c1ZiVEJENlE1OG96LTFjLTJOX1E2ZU1nN3p4TVpJVmJpbklDeUZaY1MtblNha3FBVzd2ZktQeFA1cG1fV285N1VQNlR4ajZJMlhQdUpmSTIxbktyVE4zMmpvcUREZUdtZHhUX3EwVEpCVVFIMnV4bHVMUWJoZE53c1R0Ml9ISVZubklpVHVCYXo3RlB6Y2pfNFRlczBROUxPQ0RpdXY?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Transgene and NEC Bio Sign License Agreement to Prepare the Next Steps of the Development of TG4050 in Head and Neck Cancer", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxObW13TmVBVjFNNVFxTHh2QkNRaUpGNzl6b08yQmowa1dFMVZpVWc5OEVWOHEtQXIzdmN3ajhHMm1OVlJQVU5oWGwyMWZPTVBmRGVzSDlVWVc0OGxRc0c1NWFiQ2doV1Ryd1NUUUdsaEE2RHE2M2liMHhDNW5FbUZuTml6NXlHZw?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Transgene Successfully Completes a Fundraising of c. \u20ac105 Million", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxQeDJwQkFaM0RTQ1dlZDNuYnFtUnpGanQtVmdGczN1VFBnaTFqMWgzRkhjNDh5WUZTZ1Q4ZWlwSE5ZVkhqczBrNV81RVJjWlRwd19WMnZLYWV5VG8tdkVrVXlwdHJFc2p0NC1MVFcxUDMxRkRaZUtVVkNyQ1JzOVhJSkxpZmh6VEY2c203b1JCZVpzUnVUNEtCRDBrdEFXWWtVQnE2REZiUHZVVUFRVkhralhob0J4MFg1Vnh2d29uMDU4NUNRUWtyM1Z2RFJybVBi?oc=5", "source_name": "GlobeNewswire", "published_at": "2025-11-26T08:00:00+00:00", "published_display": "26 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca ties up with France's Transgene to develop viral immunotherapies", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxNbTgzYXNzRnRDVlZEVmxVVEtnWGVtMTZsdENDdzRzMFBLRUVtT00tRXVlRWR0aGdaRU1QSlBsc1ZVYWRYMWV4bWtMYld4ME5PT0RkQlFVeG5xWlVGZTZjSXNrOGVST3EyWmVNc0M3ckQwZkpETm5LSmtrMGx4WDhPT2ozcmQxVUJkc1llTXNZcmY1UVJyb3pBdm84MUZNb3g5dWRRZGpHeGRLSktyWXJEaU9MS1dlTnJsS1FvT3dZZDZ1bTRSNkpjbTdjcw?oc=5", "source_name": "Reuters", "published_at": "2019-05-02T07:00:00+00:00", "published_display": "02 May 2019 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Transgene SA (TRGNF) Discusses Progress in Individualized Neoantigen Therapeutic Vaccines and Expansion into Early-Stage NSCLC - Slideshow (OTCMKTS:TRGNF) 2026-07-01", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxPUXVHYkNmT3JRdGZaa2Q0UC0ybFpOdHpOcmN2TWhpWEZnWjY4WUl1c1ZiVEJENlE1OG96LTFjLTJOX1E2ZU1nN3p4TVpJVmJpbklDeUZaY1MtblNha3FBVzd2ZktQeFA1cG1fV285N1VQNlR4ajZJMlhQdUpmSTIxbktyVE4zMmpvcUREZUdtZHhUX3EwVEpCVVFIMnV4bHVMUWJoZE53c1R0Ml9ISVZubklpVHVCYXo3RlB6Y2pfNFRlczBROUxPQ0RpdXY?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Transgene and NEC Bio Sign License Agreement to Prepare the Next Steps of the Development of TG4050 in Head and Neck Cancer", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxObW13TmVBVjFNNVFxTHh2QkNRaUpGNzl6b08yQmowa1dFMVZpVWc5OEVWOHEtQXIzdmN3ajhHMm1OVlJQVU5oWGwyMWZPTVBmRGVzSDlVWVc0OGxRc0c1NWFiQ2doV1Ryd1NUUUdsaEE2RHE2M2liMHhDNW5FbUZuTml6NXlHZw?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Transgene Successfully Completes a Fundraising of c. \u20ac105 Million", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxQeDJwQkFaM0RTQ1dlZDNuYnFtUnpGanQtVmdGczN1VFBnaTFqMWgzRkhjNDh5WUZTZ1Q4ZWlwSE5ZVkhqczBrNV81RVJjWlRwd19WMnZLYWV5VG8tdkVrVXlwdHJFc2p0NC1MVFcxUDMxRkRaZUtVVkNyQ1JzOVhJSkxpZmh6VEY2c203b1JCZVpzUnVUNEtCRDBrdEFXWWtVQnE2REZiUHZVVUFRVkhralhob0J4MFg1Vnh2d29uMDU4NUNRUWtyM1Z2RFJybVBi?oc=5", "source_name": "GlobeNewswire", "published_at": "2025-11-26T08:00:00+00:00", "published_display": "26 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca ties up with France's Transgene to develop viral immunotherapies", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxNbTgzYXNzRnRDVlZEVmxVVEtnWGVtMTZsdENDdzRzMFBLRUVtT00tRXVlRWR0aGdaRU1QSlBsc1ZVYWRYMWV4bWtMYld4ME5PT0RkQlFVeG5xWlVGZTZjSXNrOGVST3EyWmVNc0M3ckQwZkpETm5LSmtrMGx4WDhPT2ozcmQxVUJkc1llTXNZcmY1UVJyb3pBdm84MUZNb3g5dWRRZGpHeGRLSktyWXJEaU9MS1dlTnJsS1FvT3dZZDZ1bTRSNkpjbTdjcw?oc=5", "source_name": "Reuters", "published_at": "2019-05-02T07:00:00+00:00", "published_display": "02 May 2019 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 76, "total_relevant": 4, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 3, "score": 55, "total": 4, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 80, "events": [{"event": "general", "label": "Market update", "weight": 2.9, "count": 4}], "positive_events": 1, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 0.76, "latest_week": "2026-07-10", "one_week_move": 0.3, "four_week_move": -1.6, "twelve_week_move": -1.8, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.260191, "market_dynamics_buy_signal": false, "relative_strength": -22.551121, "fair_value_gap": -27.8, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 39.365, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.3% over one week, -1.6% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 54, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Seeking Alpha", "count": 1}, {"label": "Market source", "count": 1}, {"label": "GlobeNewswire", "count": 1}, {"label": "Reuters", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 4}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 4}]}, "insights": [{"label": "Weighted tone", "value": "55/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "80/100 classification confidence."}, {"label": "Company focus", "value": "4", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+0.3% over one week, -1.6% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Transgene SA (TRGNF) Discusses Progress in Individualized Neoantigen Therapeutic Vaccines and Expansion into Early-Stage NSCLC - Slideshow (OTCMKTS:TRGNF) 2026-07-01"}], "updated_at": "2026-07-17T08:10:00.912291+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}